No Cover Image

Journal article 359 views

A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer

Fabrizio Pertusati, Salvatore Ferla Orcid Logo, Marcella Bassetto Orcid Logo, Andrea Brancale, Sahar Khandil, Andrew D. Westwell, Christopher McGuigan

European Journal of Medicinal Chemistry, Volume: 180, Pages: 1 - 14

Swansea University Authors: Salvatore Ferla Orcid Logo, Marcella Bassetto Orcid Logo

Full text not available from this repository: check for access using links below.

Published in: European Journal of Medicinal Chemistry
ISSN: 0223-5234
Published: Elsevier BV 2019
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa52218
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: Pentafluorosulfanyl; Pentafluoroethyl; Prostate cancer; Androgen receptor; Antiproliferative activity; Enobosarm; Bicalutamide; Enzalutamide
College: College of Science
Start Page: 1
End Page: 14